The Latest Breaking News from Drug Enforcement Administration

Despite an overdose epidemic that killed 107,000 people last year, nearly 9 in 10 Americans who need medication to treat their addiction to deadly opioids aren’t receiving it.

The U.S. remains in the midst of an ever-worsening drug overdose crisis. Because prescription opioids drove its earlier phases, the nation responded by drastically reducing access to those drugs — with prescriptions dropping by nearly 50% over the last decade. But it’s now clear that approach was ineffective at combating…

More than 397 million fatal fentanyl doses have been intercepted this year with just two milligrams enough to be deadly, according to the Drug Enforcement Administration

LOS ANGELES — In the last two months, agents with Homeland Security Investigations have seized as much fentanyl as they did in all of 2019, federal officials said, warning that the amount of the drug hitting the streets is increasing every year with deadly consequences.

The Drug Enforcement Administration (DEA) is proposing a significant increase in the amount of research cannabis allowed to be cultivated in 2023.

The Drug Enforcement Administration is warning that drug dealers are marketing rainbow-colored fentanyl to kids. Many drug experts say that's likely not happening.

DEA Seizes Alarming Amount Of Fentanyl As Overdose Deaths Continue To Soar The Drug Enforcement Administration has seized over 10 million fentanyl pills and roughly 980 pounds of fentanyl powder as part of its enforcement operation conducted from May to September.

For the Drug Enforcement Administration (DEA), physicians who seek psilocybin for their dying patients under federal Right to Try (RTT) laws are making a request for a ‘commercial use.’ The DEA is implying that doctors who want to give terminally ill patients psilocybin have a financial interest, making them ineligible for a f

Since 1985, when US DEA agent, Kiki Camarena was killed, a task force has sought to capture the man accused of being involved in the death, now he’s behind bars once again. Kevin Sieff and Mary Beth Sheridan tell the story

The Drug Enforcement Administration (DEA) has refused once more to a petition from a doctor to treat terminally-ill patients with psilocybin therapy, following federal and state “Right to Try” (RTT) laws. The agency is being takento court in a new case.

A group of terminally ill patients seeking psilocybin therapy will likely take the Drug Enforcement Administration (DEA) to federal court once again over the agency’s denial to grant access to the treatment under Right To Try (RTT) laws, The Microdose